Boston Scientific (BSX) Accumulated Depreciation & Amortization (2009 - 2026)

Boston Scientific's Accumulated Depreciation & Amortization history runs 18 years deep, the most recent figure standing at $351.0 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization rose 8.0% year-over-year to $351.0 million; the TTM figure through Mar 2026 stood at $351.0 million (up 8.0% YoY), while the FY2025 annual figure was $1.4 billion, up 7.8% from the prior year.
• Accumulated Depreciation & Amortization came in at $351.0 million for Q1 2026 at Boston Scientific, down from $1.4 billion in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.4 billion in Q4 2025 to a low of $274.0 million in Q1 2022.
• A 5-year average of $739.6 million and a median of $661.0 million in 2025 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization rose 2.24% in 2022 and gained 8.9% in 2025, its largest moves.
• Boston Scientific's Accumulated Depreciation & Amortization stood at $1.1 billion in 2022, then gained by 5.28% to $1.2 billion in 2023, then gained by 6.1% to $1.3 billion in 2024, then advanced by 7.8% to $1.4 billion in 2025, then slumped by 74.34% to $351.0 million in 2026.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $351.0 million, $1.4 billion, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison